col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


51 Results       Page 1

 [1] 
Elsevier: Journal of Immunological Methods
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―14 Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study Nejla Stambouli, Khadija Bahrini, Chihebeddine Romdhani, Aicha Rebai, Sana Boughariou, Mohamed Zakraoui, et al. (+8)
2 [GO] 2023―Nov―30 Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen Linwood Johnson, Maggie L. Bartlett, Francisco Ramirez, Christopher D. Heger, Darci R. Smith
3 [GO] 2023―Sep―11 Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development Michelle Teixeira de Almeida, Ana Paula Barbosa, Camila Gasque Bomfim, Aline Biazola Visnardi, Tania Churasacari Vinces, Alexandre Ceroni, et al. (+2)
4 [GO] 2023―Sep―06 Optimisation of SARS-CoV-2 peptide stimulation and measurement of cytokine output by intracellular flow cytometry and bio-Plex analysis Jemma Victoria Taylor, Emma Louise Callery, Anthony Rowbottom
5 [GO] 2023―Aug―10 Performance comparison of three commercial tests for the detection of SARS-CoV-2 antibodies in a common set of pediatric samples Sophonie J. Oyeniran, Huanyu Wang, Kathy Everhart, Kathy Mack, Kevin Harvey, Amy L. Leber
6 [GO] 2023―Jun―29 Effect of wash media type during PBMC isolation on downstream characterization of SARS-CoV-2-specific T cells Zion Congrave-Wilson, Minjun Kim, Aaron Sutherland, Jaycee Jumarang, Yesun Lee, Jennifer Del Valle, et al. (+3)
7 [GO] 2023―May―19 Anti-N SARS-CoV-2 assays for evaluation of natural viral infection Aurelia Gaeta, Antonio Angeloni, Anna Napoli, Beatrice Pucci, Lilia Cinti, Piergiorgio Roberto, et al. (+5)
8 [GO] 2023―May―16 Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults P. Ferentinos, D. Snape, F. Koivula, S. Faustini, A. Nicholson-little, M. Stacey, et al. (+9)
9 [GO] 2023―May―11 Development and validity assessment of ELISA test with recombinant chimeric protein of SARS-CoV-2 Zoraida Fernandez, Rudielle de Arruda Rodrigues, Jaire Marinho Torres, Gláucia Barbosa Marcon, Eduardo de Castro Ferreira, Vanessa Felipe de Souza, et al. (+13)
10 [GO] 2023―May―11 Clinical evaluation of commercial SARS-CoV-2 serological assays in a malaria endemic setting Djeneba Dabitao, Kathryn Shaw-Saliba, Drissa S. Konate, Helene C. Highbarger, Perrine Lallemand, Ibrahim Sanogo, et al. (+14)
11 [GO] 2023―Apr―12 Comparative evaluation of Luminex based assays for detection of SARS-CoV-2 antibodies in a transplantation laboratory A. Cox, M. Stevens, D. Kallon, A. Gupta, E. White
12 [GO] 2023―Mar―11 A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials Hélène Bisceglia, Julie Barrier, Joseline Ruiz, Anke Pagnon
13 [GO] 2023―Feb―25 An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV2 immune individuals Tiziana Altosole, Gianluca Rotta, Chiara R.M. Uras, Scott J. Bornheimer, Daniela Fenoglio
14 [GO] 2023―Feb―10 Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses Nora Pisanic, Annukka A.R. Antar, Kate L. Kruczynski, Magdielis Gregory Rivera, Santosh Dhakal, Kristoffer Spicer, et al. (+9)
15 [GO] 2023―Feb―01 Elevation of truncated (48 kDa) form of unconventional myosin 1C in blood serum correlates with severe Covid-19 Yuriy Kit, Marina Starykovych, Nazar Manko, Andrii Orfin, Tamila Alexanyan, Lydmyla Bozhko, et al. (+7)
16 [GO] 2022―Dec―31 Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing Matthew D. Sims, Robert H. Podolsky, Karen L. Childers, Barbara Higgins, Jillian Trueman, Ramin Homayouni, et al. (+5)
17 [GO] 2022―Oct―25 Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice Lachlan P. Deimel, Xin Liu, Javier Gilbert-Jaramillo, Sai Liu, William S. James, Quentin J. Sattentau
18 [GO] 2022―Oct―04 Novel bridge multi-species ELISA for detection of SARS-CoV-2 antibodies Aldana Trabucchi, Silvina Sonia Bombicino, Juan Ignacio Marfía, Adriana Victoria Sabljic, Rubén Francisco Iacono, Ignacio Smith, et al. (+7)
19 [GO] 2022―Sep―07 COVID-19 in patients with B cell immune deficiency Paschalis Vergidis, Emily R. Levy, Elizabeth H. Ristagno, Vivek N. Iyer, John C. O'Horo, Avni Y. Joshi
20 [GO] 2022―Aug―30 Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination Grace Kenny, Riya Negi, Sophie O'Reilly, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+11)
21 [GO] 2022―Aug―17 Digital RT-PCR Chip method for detection of SARS-CoV-2 virus Laura Dioni, Annarosa Orlandi, Sara Uceda Renteria, Chiara Favero, Giulia Solazzo, Massimo Oggioni, Valentina Bollati
22 [GO] 2022―Jun―02 Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine Davide Ferrari, Alessandro Ambrosi, Chiara Di Resta, Rossella Tomaiuolo, Massimo Locatelli, Giuseppe Banfi
23 [GO] 2022―May―07 Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice Qian Ke, Peng Sun, Tiantian Wang, Taotao Mi, Huifang Xu, Jun Wu, Bo Liu
24 [GO] 2022―Apr―16 Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA Huy Quang Quach, Inna G. Ovsyannikova, Gregory A. Poland, Richard B. Kennedy
25 [GO] 2022―Mar―15 Application of the SARS-CoV-2-S1 ACE-2 receptor interaction as the basis of the fully automated assay to detect neutralizing SARS-CoV-2-S1 antibodies in blood samples Daniel Filchtinski, Magnus Sundberg, Heike Berthold, Laura Steller, Kayser José, Sanja Holz, et al. (+4)
26 [GO] 2022―Feb―23 The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies Shuangzhe Zhang, Chunhui Gao, Tuhin Das, Shuhong Luo, Hao Tang, Xinyi Yao, et al. (+6)
27 [GO] 2022―Feb―16 Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests Gabriel N. Maine, Subhashree Mallika Krishnan, Kelly Walewski, Jillian Trueman, Elizabeth Sykes, Qian Sun
28 [GO] 2022―Jan―31 Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination Vincenzo Grimaldi, Giuditta Benincasa, Giusi Moccia, Annunziata Sansone, Giuseppe Signoriello, Claudio Napoli
29 [GO] 2022―Jan―07 A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation Jose Marchan
30 [GO] 2022―Jan―06 Role of antinuclear antibodies in COVID-19 patients Linda Beenet
31 [GO] 2021―Nov―26 Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects Alessandro Manenti, Elena Gianchecchi, Francesca Dapporto, Margherita Leonardi, Paolo Cantaloni, Filippo Fattorini, et al. (+6)
32 [GO] 2021―Nov―26 Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials Omar R. Blanco, Dayamí Dorta, Carlos A. Hernández, Daymí Abreu, Andy G. Domínguez, Yaramis Luna, et al. (+11)
33 [GO] 2021―Nov―08 Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19 Luciana Villafañe, Lucía Gallo Vaulet, Florencia M. Viere, Laura I. Klepp, Marina A. Forrellad, María M. Bigi, et al. (+4)
34 [GO] 2021―Oct―30 Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis Bilal Olcay Peker, Aslı Gamze Şener, Figen Kaptan Aydoğmuş
35 [GO] 2021―Oct―11 Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination Pratik Datta, Rahul Ukey, Natalie Bruiners, William Honnen, Mary O. Carayannopoulos, Charles Reichman, et al. (+29)
36 [GO] 2021―Sep―30 Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples Sasha E. Larsen, Bryan J. Berube, Tiffany Pecor, Evan Cross, Bryan P. Brown, Brittany Williams, et al. (+9)
37 [GO] 2021―Sep―28 A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2 Sara Lind Enoksson, Peter Bergman, Jonas Klingström, Fredrik Boström, Rui Da Silva Rodrigues, Malin Winerdal, Per Marits
38 [GO] 2021―Jul―22 Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma Leah Huey, Gillian Andersen, Patricia A. Merkel, Thomas E. Morrison, Mary McCarthy, Melkon G. DomBourian, et al. (+4)
39 [GO] 2021―Jul―06 Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response Anura David, Lesley Scott, Sarika Jugwanth, Maemu Gededzha, Trish Kahamba, Nontobeko Zwane, et al. (+4)
40 [GO] 2021―Apr―26 SARS-CoV-2 serology testing: Progress and challenges Aria C. Shi, Ping Ren
41 [GO] 2021―Mar―27 SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing Clive Carter, Pamela Hughes, Anna McHugh, Fatima Nadat, Penny Lewthwaite, Sinisa Savic, Brendan Clark
42 [GO] 2021―Mar―26 Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients A.M. Cook, S.E. Faustini, L.J. Williams, A.F. Cunningham, M.T. Drayson, A.M. Shields, et al. (+13)
43 [GO] 2021―Mar―24 Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response Marnix Mylemans, Eveline Van Honacker, Louis Nevejan, Stefanie van den Bremt, Laura Hofman, Jeroen Poels, et al. (+3)
44 [GO] 2021―Feb―11 Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2 Ianko Iankov, Kimberly Viker, Coleman Turgeon, Dietrich Matern, Evanthia Galanis
45 [GO] 2021―Jan―07 Development and characterization of an indirect ELISA to detect SARS-CoV - 2 spike protein-specific antibodies Verena Krähling, Sandro Halwe, Cornelius Rohde, Dirk Becker, Susanne Berghöfer, Christine Dahlke, et al. (+10)
46 [GO] 2020―Nov―28 Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples Livia Mazzini, Donata Martinuzzi, Inesa Hyseni, Linda Benincasa, Eleonora Molesti, Elisa Casa, et al. (+7)
47 [GO] 2020―Nov―07 Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples Margaret A. Black, Guomiao Shen, Xiaojun Feng, Wilfredo F. Garcia Beltran, Yang Feng, Varshini Vasudevaraja, et al. (+10)
48 [GO] 2020―Oct―31 SARS-CoV-2 variants lacking a functional ORF8 may reduce accuracy of serological testing Filipe Pereira
49 [GO] 2020―Aug―20 Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays Melkon G. DomBourian, Kyle Annen, Leah Huey, Gillian Andersen, Patricia A. Merkel, Sarah Jung, et al. (+2)
50 [GO] 2020―Aug―08 SARS-CoV-2-specific ELISA development Vicky Roy, Stephanie Fischinger, Caroline Atyeo, Matthew Slein, Carolin Loos, Alejandro Balazs, et al. (+18)
51 [GO] 2020―Jun―17 Agrodiag PorCoV: A multiplex immunoassay for the differential diagnosis of porcine enteric coronaviruses Rémi Malbec, Kay Kimpston-Burkgren, Elisa Vandenkoornhuyse, Christophe Olivier, Vianney Souplet, Christophe A�rt, et al. (+3)
 [1] 

51 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.011 sec